AdaptHealth Target of Unusually Large Options Trading (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) was the target of some unusual options trading on Thursday. Traders purchased 41,622 put options on the stock. This is an increase of 1,002% compared to the average volume of 3,777 put options.

Institutional Investors Weigh In On AdaptHealth

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AHCO. Blue Trust Inc. increased its position in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares during the period. Quarry LP grew its holdings in AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after acquiring an additional 5,838 shares during the period. CIBC Asset Management Inc acquired a new stake in AdaptHealth in the 3rd quarter valued at about $122,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares in the last quarter. Finally, MBB Public Markets I LLC bought a new position in shares of AdaptHealth during the 2nd quarter valued at about $142,000. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Trading Up 0.8 %

Shares of AHCO stock opened at $10.71 on Friday. AdaptHealth has a 1 year low of $6.91 and a 1 year high of $11.90. The firm has a market capitalization of $1.44 billion, a PE ratio of -6.49, a price-to-earnings-growth ratio of 1.32 and a beta of 1.09. The stock has a fifty day moving average of $9.98 and a two-hundred day moving average of $10.38. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The company had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. During the same period in the previous year, the company earned $0.19 EPS. The business’s revenue for the quarter was up .2% compared to the same quarter last year. As a group, research analysts expect that AdaptHealth will post 0.88 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Robert W. Baird decreased their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Wednesday, November 6th. Canaccord Genuity Group decreased their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Truist Financial dropped their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. UBS Group lowered their price objective on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada cut their target price on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $12.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.